Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 1,860,288 |
|
|||||
| News | - | ||||||
| Day High | 0.1703 | Low High |
|||||
| Day Low | 0.1597 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corporation | TNXP | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01005 | 6.28% | 0.17 | 18:50:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.16 | 0.1597 | 0.1703 | 0.1685 | 0.15995 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,862 | 1,860,288 | US$ 0.1661757 | US$ 309,135 | - | 0.1202 - 3.3125 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:46:41 | formt | 100 | US$ 0.17 | USD |
Tonix Pharmaceuticals Holding Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.96M | 58.61M | - | 7.77M | -116.66M | -1.99 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Tonix Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TNXP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1503 | 0.1703 | 0.149 | 0.158107 | 1,207,371 | 0.0197 | 13.11% |
| 1 Month | 0.202 | 0.202 | 0.1202 | 0.1731912 | 3,224,913 | -0.032 | -15.84% |
| 3 Months | 0.355 | 0.39 | 0.1202 | 0.2425929 | 2,303,024 | -0.185 | -52.11% |
| 6 Months | 0.5546 | 0.6918 | 0.1202 | 0.3120678 | 1,869,196 | -0.3846 | -69.35% |
| 1 Year | 2.8894 | 3.3125 | 0.1202 | 0.5607696 | 1,162,927 | -2.72 | -94.12% |
| 3 Years | 6.375 | 29.9375 | 0.1202 | 4.08 | 8,366,112 | -6.21 | -97.33% |
| 5 Years | 137.50 | 155.625 | 0.1202 | 5.70 | 9,773,654 | -137.33 | -99.88% |
Tonix Pharmaceuticals Description
| Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio is composed of immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. Tonix's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500 which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Tonix's rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome. |
